Provided by Tiger Trade Technology Pte. Ltd.

Dyne Therapeutics, Inc.

17.14
-1.4100-7.60%
Post-market: 17.140.00000.00%17:50 EDT
Volume:1.77M
Turnover:31.10M
Market Cap:2.83B
PE:-4.93
High:18.92
Open:18.43
Low:17.07
Close:18.55
52wk High:25.00
52wk Low:6.36
Shares:165.03M
Float Shares:152.00M
Volume Ratio:0.64
T/O Rate:1.17%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4740
EPS(LYR):-3.4740
ROE:-55.71%
ROA:-31.16%
PB:2.91
PE(LYR):-4.93

Loading ...

Dyne Therapeutics, Inc. : Oppenheimer Raises to Outperform From Perform

THOMSON REUTERS
·
Dec 10, 2025

Dyne Therapeutics Prices $350 Million Public Offering

MT Newswires Live
·
Dec 10, 2025

BRIEF-Dyne Therapeutics Says Co Prices Public Offering At $18.44 Per Share

Reuters
·
Dec 10, 2025

Dyne Therapeutics Inc - Public Offering Priced at $18.44 per Share, $350 Mln Expected Proceeds

THOMSON REUTERS
·
Dec 10, 2025

Dyne Therapeutics Announces Pricing of Upsized $350.0 Million Public Offering of Common Stock

GlobeNewswire
·
Dec 10, 2025

Dyne Therapeutics Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Dec 10, 2025

Dyne Therapeutics Shares Fall 14.7% After Unveiling $300 Mln Stock Offering

THOMSON REUTERS
·
Dec 10, 2025

BUZZ-Dyne Therapeutics slides after unveiling $300 million stock offering

Reuters
·
Dec 10, 2025

Dyne Therapeutics' Recent DMD Study Data Further Validates Force Platform, Morgan Stanley Says

MT Newswires Live
·
Dec 10, 2025

Morgan Stanley Raises Price Target on Dyne Therapeutics to $50 From $46, Keeps Overweight Rating

MT Newswires Live
·
Dec 09, 2025

Dyne Therapeutics Inc : Bernstein Raises Target Price to $23 From $21

THOMSON REUTERS
·
Dec 09, 2025

U.S. RESEARCH ROUNDUP-AstraZeneca, Confluent, Pepsico

Reuters
·
Dec 09, 2025

Dyne Therapeutics Secures $50 Million Loan Tranche in Amended Financing Agreement with Hercules Capital

Reuters
·
Dec 09, 2025

BRIEF-Dyne Therapeutics Announces Proposed Public Offering Of Common Stock

Reuters
·
Dec 09, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Five Below, Boeing, Instacart

Reuters
·
Dec 09, 2025

Dyne Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Dec 08, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Micron, NextEra Energy, Ocular Therapeutix

Reuters
·
Dec 08, 2025

Dyne Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $60 From $46

THOMSON REUTERS
·
Dec 08, 2025

BRIEF-Dyne Therapeutics Announces Positive Topline Results From Phase 1/2 Deliver Trial

Reuters
·
Dec 08, 2025

Dyne Therapeutics Shares up 3.6% Premarket After Co Reports Early-to-Mid Stage Trial Data for Muscle Disorder Drug

THOMSON REUTERS
·
Dec 08, 2025